News | Queen Square Analytics

News

Company news, research and events from Queen Square Analytics.

Latest · 5 March 2026

Autolus Pioneers CAR-T Cell MS Treatment

QSA congratulates Autolus for achieving its historic milestone dosing the first patient with its pioneering BOBCAT trial of obecabtagene autoleucel (obe-cel), a ‘one-time’ immunotherapy treatment for progressive multiple sclerosis (PMS). QSA is providing advanced imaging analytics in support of this groundbreaking work.

Read the post

2026

19 Jan 2026ARIAEducation.eu Online Resource (v1) Launched
10 Jan 2026Are we ready for amyloid-related imaging abnormalities (ARIA) monitoring?

2025

30 Dec 2025QSA's AI analysis of blood tests and MRI scans reveal two distinct types of multiple sclerosis

2023

24 Nov 2023System for Brain MRI Scan Quality with potential for Enhancing Patient Care
1 Aug 2023Bioxydyn and QSA Partner to Provide Advanced Neurological Clinical Trials
12 Jun 2023Emerging Perspectives on the use of MRI in MS
15 Apr 2023DeepBrainPrint: A Novel Contrastive Framework for Brain MRI Re-Identification

2022

14 Nov 2022ECTRIMS 2022 Overview
20 Oct 2022QSA at ECTRIMS 2022
17 Jun 2022Reducing the Price of MS Uncertainty

Planning a neurology trial?

Tell us about your study and the imaging questions behind it.

Email enquiries@queensquareanalytics.comEmail us